Literature DB >> 9606678

[Therapy of cerebral arteriovenous malformations].

H Mast1, H C Koennecke, J Meisel, A Osipov, A Hartmann, P Lasjaunias, J Pile-Spellman, L Hacein-Bey, W L Young, J P Mohr.   

Abstract

The rapid development of modern endovascular, microsurgical, and radiation therapies has considerably expanded the treatment options for encephalic arteriovenous malformations (AVMs). Surgery has the longest history. Single or staged intravascular procedures (embolizations) using fast-acting glues, sclerotic agents, and thrombogenic coils serve to reduce the size of AVM to that suitable for extirpation and may reduce the risk of surgery. Radiation ("gamma-knife") therapy, most frequently used in small, non-operable AVMs, is also viewed by some authors as an alternative or even superior tool in small, operable malformations. Partial embolization to reduce the mass-effect of space-occupying AVMs, to reverse diaschisis, and to treat AVM-related seizure disorders is being discussed and practiced. Given the in part competing or even controversial options, the selection of optimal treatment for AVM patients is becoming increasingly difficult. Current management is impeded by the paucity of information on the exact risks of invasive therapies and by insufficient criteria for identifying patients at risk of spontaneous bleeding during the natural course, including the seriousness of such hemorrhage.

Entities:  

Mesh:

Year:  1998        PMID: 9606678     DOI: 10.1007/s001150050272

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  2 in total

1.  De novo cerebral arteriovenous malformations: is epileptic seizure a potential trigger?

Authors:  Jun Wu; Yu Li; Yong Cao; Shuo Wang
Journal:  Childs Nerv Syst       Date:  2014-04-09       Impact factor: 1.475

2.  Dexmedetomidine may impair cognitive testing during endovascular embolization of cerebral arteriovenous malformations: a retrospective case report series.

Authors:  Maria A Bustillo; Ronald M Lazar; A Donald Finck; Brian Fitzsimmons; Mitchell F Berman; John Pile-Spellman; Eric J Heyer
Journal:  J Neurosurg Anesthesiol       Date:  2002-07       Impact factor: 3.956

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.